Marijuana both constricts and dilates blood vessels, and the direction depends on which blood vessel you’re looking at, how much THC is involved, and whether use is acute or chronic. That “it depends” answer frustrates people searching for a simple yes or no, but the vascular system responds to cannabinoids in genuinely opposing ways across different tissues. The blood vessels in your eyes dilate (which is why your eyes turn red), while coronary arteries can spasm and narrow. Understanding which vessels go which way, and why, turns out to matter quite a bit for health.
Different Blood Vessels, Different Responses
The most visible example of marijuana-induced vasodilation is right on your face. THC binds to cannabinoid receptors in the eye, dilating the small blood vessels of the conjunctiva in a dose-dependent fashion. More THC means more blood flow to the surface of the eye, which is what produces the classic redness that gives away recent use.1PubMed Central. Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review This is straightforward vasodilation, and it happens reliably.
In the brain, the picture shifts. Experienced marijuana smokers show a significant bilateral increase in cerebral blood flow, especially in the frontal regions, right after smoking.2PubMed. Acute changes in cerebral blood flow after smoking marijuana That increase suggests vasodilation of cerebral arteries during acute use. But a systematic review of the broader literature found the relationship is more nuanced: acute cannabis use tends to increase cerebral blood flow overall, while chronic use is associated with decreased cerebral blood flow, a pattern that appears to be at least partially reversible after stopping.3Progress in Neuro-Psychopharmacology and Biological Psychiatry. Acute and chronic effects of Δ9-tetrahydrocannabinol (THC) on cerebral blood flow: A systematic review
In the coronary arteries feeding the heart, the story flips toward constriction. THC can trigger coronary vasospasm through a surge of catecholamines (stress hormones like adrenaline), increasing the heart’s oxygen demand while simultaneously narrowing the vessels that supply it.4Cardiovascular Revascularization Medicine: Interesting Cases. A Rare Case of Cannabis-Induced Left Main Coronary Artery Vasospasm: A Case Report and Review of Literature In the peripheral vasculature, THC activates what’s called the CB1 receptor on blood vessel walls, promoting oxidative stress, inflammation, and constriction that can contribute to arterial disease over time.5PubMed. Marijuana and Peripheral Vascular Disease: Pathophysiology, Clinical Evidence, and Cardiovascular Implications
So the same compound dilates blood vessels in some tissues and constricts them in others. The Canadian Medical Association Journal summed it up neatly: cannabis causes “dose-dependent tachycardia and either vasoconstriction or vasodilation, as well as orthostatic hypotension.”6PubMed Central. Drug interactions with cannabinoids This dual nature is not a contradiction. Different vascular beds have different densities of cannabinoid receptors and different autonomic nervous system wiring, so they respond differently to the same circulating compound.
The Acute Heart Rate and Blood Pressure Spike
Within minutes of smoking or vaping marijuana, most people experience a noticeable increase in heart rate. THC stimulates the sympathetic nervous system, the body’s fight-or-flight wiring, which drives up heart rate and can raise blood pressure transiently. At the same time, there’s a paradoxical drop in peripheral vascular resistance, the overall tightness of blood vessels throughout the body, that can cause a drop in blood pressure when you stand up. This is called orthostatic hypotension, and it’s why some users feel dizzy or lightheaded after standing up quickly.7PubMed. Cardiovascular consequences of marijuana use
These two effects happening simultaneously, heart rate going up while peripheral resistance drops, illustrate the push-and-pull that makes marijuana’s vascular effects so hard to pin to a single label. The overall cardiovascular response involves the autonomic nervous system and the endocannabinoid system working together, sometimes in opposition. In animal studies, blocking the degradation of the body’s own endocannabinoid (anandamide) lowers blood pressure, heart contractility, and vascular resistance, effects that disappear when the CB1 receptor is blocked.8PubMed Central. Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension This tells us that the CB1 receptor is a major switch in regulating vascular tone, and flooding the system with external THC throws that switch in ways the body didn’t calibrate for.
Acute Versus Chronic Use
One of the clearest patterns in the research is that acute and chronic marijuana use often have opposite effects on blood flow in the brain. As mentioned, smoking marijuana once increases cerebral blood flow. But people who use cannabis daily for months or years tend to show reduced resting cerebral blood flow compared to nonusers. A study of chronic cannabis users who had abstained for 72 hours found that their global resting cerebral blood flow still correlated with THC levels in their system, and they had higher blood flow in certain deep brain structures compared to nonusers, but the overall trajectory of chronic use pointed toward reduced perfusion.9PubMed Central. Residual Effects of THC via Novel Measures of Brain Perfusion and Metabolism in a Large Group of Chronic Cannabis Users The systematic review of the topic described these changes as “region-specific, dose-dependent alterations” that appear “potentially reversible” after quitting.3Progress in Neuro-Psychopharmacology and Biological Psychiatry. Acute and chronic effects of Δ9-tetrahydrocannabinol (THC) on cerebral blood flow: A systematic review
The reversibility is important. It suggests that long-term marijuana use isn’t permanently damaging cerebral blood vessels in most people but is chronically shifting their baseline tone, likely through some combination of receptor desensitization and changes to the signaling pathways that regulate vessel diameter. When the THC exposure stops, vessels appear to recover their normal caliber over time.
CBD Has a Different Vascular Profile
Not all cannabinoids are THC. Cannabidiol (CBD), the other major compound in cannabis, has its own vascular effects, and they lean more consistently toward relaxation. In lab studies using human pulmonary arteries and mesenteric arteries (the blood vessels supplying the gut), CBD caused dose-dependent relaxation of pre-constricted vessels.10PubMed Central. Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities Separately, researchers showed that CBD relaxed human mesenteric arteries by about 40% through a mechanism that depends on the inner lining of the blood vessel (the endothelium) and involves the CB1 receptor.11PubMed Central. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation
This is an interesting wrinkle because the same CB1 receptor that THC uses to promote vasoconstriction in coronary and peripheral arteries appears to mediate vasodilation when CBD activates it, at least in certain vascular beds. The reason probably involves differences in downstream signaling. CBD increased the activity of an enzyme in endothelial cells that produces nitric oxide, the body’s primary vasodilator molecule.11PubMed Central. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation THC doesn’t reliably do this, and in some contexts appears to suppress it.
The practical implication is that different cannabis products, depending on their THC-to-CBD ratio, could have quite different effects on your blood vessels. A high-THC strain with minimal CBD is not the same pharmacological exposure as a high-CBD product. Whether CBD’s vasodilatory properties translate into cardiovascular protection in real-world use is still unproven in human clinical trials, but the bench science is consistent.
Coronary Vasospasm and Heart Risk
The most alarming vascular effect linked to marijuana is coronary vasospasm, where the arteries feeding the heart suddenly clamp down, reducing or cutting off blood flow. This can mimic or cause an actual heart attack, and it has been documented in case reports even in young, otherwise healthy users. One epidemiological analysis found the risk of heart attack was about 4.8 times higher than baseline in the first 60 minutes after using cannabis, though that risk dropped quickly afterward.12PubMed Central. Marijuana-induced Coronary Vasospasm with Persistent Inter-coronary Connection: A Case Report and Review of Literature In population terms, the overall attributable risk remained low, especially compared to stimulants, but the acute window of vulnerability is real.
The mechanism behind coronary vasospasm involves the same catecholamine surge that makes the heart beat faster. Adrenaline constricts coronary vessels while simultaneously increasing the heart’s demand for oxygen, a dangerous mismatch. THC also stimulates the CB1 receptor on coronary artery walls, which has pro-atherogenic (plaque-promoting) properties.4Cardiovascular Revascularization Medicine: Interesting Cases. A Rare Case of Cannabis-Induced Left Main Coronary Artery Vasospasm: A Case Report and Review of Literature For people who already have some degree of coronary artery disease, even if they don’t know it, this combination can be enough to trigger a cardiac event.
Cannabis Arteritis and Peripheral Vascular Disease
Separate from the acute heart risks, heavy cannabis use has been linked to a chronic peripheral vascular condition called cannabis arteritis. This affects the small and medium arteries of the extremities, particularly the legs and feet, and resembles a condition historically associated with tobacco called thromboangiitis obliterans (Buerger’s disease). Patients are typically young adults, and symptoms include pain, coldness in the limbs, and in severe cases tissue death requiring amputation.13Journal of the American Academy of Dermatology. Cannabis arteritis
The mechanism is not fully pinned down. THC has a vasoconstrictor effect demonstrated in animal studies, possibly mediated through an action on the nerve endings that release adrenaline. But because many cannabis arteritis patients also smoke tobacco, arsenic from tobacco smoke may play a confounding role, contributing to blood vessel inflammation and clotting independently.14PubMed Central. Cannabis arteritis Population-based studies have found significantly increased odds of peripheral arterial disease in marijuana users even after adjusting for other risk factors, which suggests cannabis itself contributes beyond what tobacco alone explains.5PubMed. Marijuana and Peripheral Vascular Disease: Pathophysiology, Clinical Evidence, and Cardiovascular Implications
A related but distinct condition is reversible cerebral vasoconstriction syndrome (RCVS), where the arteries in the brain go into prolonged spasm. Case reports have described this in chronic daily marijuana users who developed sudden severe headaches and, in some cases, watershed strokes from sustained narrowing of cerebral arteries. The “reversible” in RCVS means that with treatment and cessation of cannabis, the vessel narrowing can resolve completely on follow-up imaging.15PubMed Central. Marijuana-related Reversible Cerebral Vasoconstriction Syndrome
Endothelial Function and How You Consume Cannabis
Beyond acute constriction or dilation, there’s growing evidence that regular marijuana use damages the endothelium, the delicate lining of blood vessels that controls their ability to dilate properly. Researchers measure this using a technique called flow-mediated dilation (FMD), which tests how well an artery opens up in response to increased blood flow. Healthy endothelium produces nitric oxide and relaxes smoothly; damaged endothelium responds sluggishly.
A 2025 study in JAMA Cardiology compared marijuana smokers, THC-edible users, and nonusers. The smokers had significantly reduced FMD (about 6%) compared to nonusers (about 10%), and edible users fared even worse at around 4.6%. Both groups showed impaired endothelial function compared to controls.16PubMed Central. Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use The edible finding surprised many people who assumed that avoiding smoke would protect blood vessels. However, the smokers showed reduced nitric oxide production in their endothelial cells while the edible users did not, suggesting the damage pathways might differ between the two routes even if the endpoint looks similar.
Inhaled marijuana aerosol itself appears to damage endothelial function regardless of THC content. A study that exposed rats to marijuana vaporizer aerosol found that FMD dropped by roughly half, and this impairment occurred even with marijuana that had virtually no THC (less than 0.01%). The aerosol particles and combustion byproducts themselves seem to harm blood vessels, much the way secondhand tobacco smoke does.17PubMed Central. Impairment of Endothelial Function by Aerosol From Marijuana Leaf Vaporizers
On top of endothelial damage, cannabis users show increased arterial stiffness. A study of young, healthy cannabis users found that both smoking and vaporizing THC-predominant cannabis increased pulse wave velocity (a measure of how rigid arteries are) acutely after use, and reduced diastolic heart function.18PubMed Central. Acute Effects of Cannabis Inhalation on Arterial Stiffness, Vascular Endothelial Function, and Cardiac Function Even habitual cannabis users at rest showed stiffer aortas compared to matched controls, though in that particular study their resting FMD was similar.19PubMed. Habitual cannabis use is associated with altered cardiac mechanics and arterial stiffness, but not endothelial function in young healthy smokers The arterial stiffness findings are especially concerning because stiff arteries are a well-established risk factor for future cardiovascular events regardless of their cause.
People on Blood Pressure Medication Should Pay Attention
Because marijuana can cause both vasodilation (lowering peripheral resistance) and a sympathetic surge (raising heart rate), combining it with blood pressure medications creates an unpredictable situation. The orthostatic hypotension that marijuana causes, that dizzy-when-standing-up feeling, can become dangerous if someone is already on drugs that lower blood pressure. Fainting and falls become a real concern.6PubMed Central. Drug interactions with cannabinoids
THC also interacts with the enzyme systems that metabolize many common medications, potentially altering how quickly drugs are cleared from the body. For someone on beta-blockers, calcium channel blockers, or other antihypertensives, marijuana use could amplify blood pressure drops at some moments and blunt the medication’s intended effects at others. This isn’t a theoretical risk: clinicians managing hypertension in states where cannabis is legal increasingly report having to adjust medications or counsel patients about timing their use.
Synthetic Cannabinoids Are a Different Beast
The vascular risks multiply with synthetic cannabinoids, the lab-made chemicals sold under names like K2 or Spice. These compounds bind the same cannabinoid receptors as THC but often with far greater potency and duration. A systematic review of their toxicity found reports of thromboembolic events, including ischemic heart disease and stroke, linked to specific synthetic compounds.20PubMed Central. Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review Because these products vary wildly in composition and potency, their vascular effects are more severe and less predictable than those of plant-derived marijuana. Emergency departments have seen clusters of strokes and heart attacks in young synthetic cannabinoid users that would be unusual even among heavy natural cannabis users.
The gap between natural cannabis and synthetic cannabinoids matters because people sometimes treat them as interchangeable. They are not. The natural plant contains dozens of compounds including CBD that may partially buffer THC’s cardiovascular effects. Synthetic products deliver a single, often extremely potent agonist with no such buffering, and the resulting vascular stress is qualitatively different.
What the Research Still Hasn’t Settled
The relationship between marijuana and atherosclerosis, the slow buildup of plaque inside arteries, remains genuinely unclear. THC activates the CB1 receptor, which is described as pro-atherogenic, while the CB2 receptor appears to be anti-atherogenic.12PubMed Central. Marijuana-induced Coronary Vasospasm with Persistent Inter-coronary Connection: A Case Report and Review of Literature Marijuana activates both. Whether the net result accelerates plaque formation, slows it, or has no meaningful effect is something the available literature has not resolved.21PubMed Central. The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High? Long-term prospective studies tracking heavy cannabis users alongside nonusers for decades, the kind of evidence that eventually settled debates about tobacco and heart disease, simply haven’t been done yet for marijuana. Most of what we know comes from case reports, cross-sectional studies, and animal work, which can identify associations and mechanisms but can’t definitively answer whether regular marijuana use will give you clogged arteries twenty years from now.
The endothelial damage findings represent perhaps the strongest indirect evidence that chronic use could promote atherosclerosis, since a poorly functioning endothelium is one of the earliest steps in plaque development. But the leap from impaired FMD measurements to actual cardiovascular events over a lifetime is a big one, and the field hasn’t bridged it yet. For now, the honest answer is that marijuana clearly affects blood vessels in multiple directions, the acute risks (vasospasm, arrhythmia, blood pressure swings) are well documented, and the long-term vascular consequences are still a genuinely open question.